Otsuka America Pharmaceutical, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$70Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
118,788clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Rexulti $27M associated (2023-2025)
- Abilify Maintena $9.2M associated (2023-2025)
- Abilify Asimtufii $7.6M associated (2023-2025)
- Jynarque $2.5M associated (2023-2025)
- Nuedexta $1.5M associated (2023-2025)
- Abilify Mycite $168K associated (2023-2025)
- Voyxact $75K associated (2023-2025)
- Tolvaptan $22K associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Rebecca Roma | Pittsburgh, PA | Psychiatry | $961,273.54 |
| Charles Tuan-Tu Nguyen | Irvine, CA | Psychiatry | $957,371.70 |
| Matthew Brams | Houston, TX | Psychiatry | $764,834.68 |
| Rifaat El-Mallakh | Louisville, KY | Psychiatry | $761,996.22 |
| Gregory Mattingley | Saint Charles, MO | Psychiatry | $713,086.79 |
| Ilan Melnick | Coral Gables, FL | Psychiatry | $690,114.51 |
| Rakesh Jain | Lake Jackson, TX | Psychiatry | $672,282.91 |
| Leslie Citrome | Pomona, NY | Psychiatry | $671,529.69 |
| Michael Measom | Slc, UT | Psychiatry | $620,197.01 |
| Kent Mcdaniel | Glen Allen, VA | Psychiatry | $587,704.67 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.